Dr. David Gregory Brabham, DO

Dr. Brabham practices at Cardiology Center of Amarillo in Amarillo, Texas.

Dr. Brabham's NPI, 1447424007, was assigned on April 15, 2008. Dr. Brabham graduated from Texas College of Osteopathic Medicine in 2004. Dr. Brabham holds Texas license M7869.

Dr. Brabham's primary practice is Cardiology Center of Amarillo, at 6200 I-40 West, Amarillo, TX 79106. The practice phone is (806) 354-9764.

Dr. Brabham's primary practice is Cardiology Center of Amarillo in Amarillo, Texas. Dr. Brabham is also affiliated with BSA Hospital. The medical group on file is Northwest Texas Healthcare System. Dmand AI also links Dr. Brabham to 4 more hospitals, 2 medical groups and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Brabham practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Brabham's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Brabham is board certified in 2015 - 2016 by the NM State License. Dr. Brabham is licensed in Texas.

Dmand AI lists aneurysm, angioplasty, arterial blot clot /embolism, atrial fibrillation and flutter, cardiac arrhythmia, cardiac catheterization, cardiomyopathy and cerebrovascular disease among the conditions Dr. Brabham treats.

CMS data shows 15,447 Medicare services from Dr. Brabham across 41 procedure codes in 2024, for 1,926 Medicare patients. Medicare paid $824,318 for them.

CMS counts 1,926 Medicare patients who saw Dr. Brabham in 2024. The largest group is 65 to 74, with 869 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.40, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Brabham's median patient age at 70, with 51% women.

In 2024, Dr. Brabham wrote 12,610 Medicare Part D claims for 1,531 patients. 80% of them were for generic drugs. CMS names the drug for 12,308 of them, across 69 drugs with 11 or more claims each, at $2,377,740 in total drug cost. In 2023, CMS named 11,262 claims across 71 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Brabham for performance year 2024, reported as part of a group. Dr. Brabham accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Brabham as offering telehealth. CMS counts 22 procedures of coronary angioplasty and stenting by Dr. Brabham, more than 53% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Brabham, published from 2018 to 2023. 2019 was the busiest year, with 2. Dr. Brabham's most frequent co-authors are Kade Carthel, MD, Totini Chatterjee and Kelly Suzanne McMaster, MD.

Dmand AI links Dr. Brabham to 1 clinical trial. Conditions studied include Heart Failure and Heart Diseases. Open Payments lists research payments to Dr. Brabham that name 2 trials.

CMS Open Payments shows 550 general payments to Dr. Brabham from 35 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 77% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $40,981. It also lists 3 research payments totaling $42,893 from 2022 to 2024, naming 2 clinical trials.

Dr. Brabham graduated from Texas College of Osteopathic Medicine in 2004. Dr. Brabham is a member of ACC.

Dr. Brabham is in network with 22 carriers, including Elevance, Blue Cross Blue Shield of Michigan and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.